Solid Tumor
Showing 76 - 100 of 763
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)
Recruiting
- Solid Tumor
- +10 more
-
Belfast, United Kingdom
- +25 more
Mar 28, 2023
Urinary System Tumor, Solid Tumor Trial in Shanghai (BL-B01D1)
Not yet recruiting
- Urinary System Tumor
- Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University ShangHai Cancer Center
Mar 26, 2023
Solid Tumor Trial in San Antonio, Tyler, Spokane (TU2218 + Pembrolizumab)
Recruiting
- Solid Tumor
- TU2218 + Pembrolizumab
-
San Antonio, Texas
- +2 more
Mar 26, 2023
Solid Tumor Trial (UCLM802 Cell Injection)
Not yet recruiting
- Solid Tumor
- UCLM802 Cell Injection
- (no location specified)
Mar 7, 2023
Refractory Tumor, Solid Tumor Trial in Kaohsiung, Tainan (Dendritic Cell Vaccine, Lenvatinib, Nivolumab)
Not yet recruiting
- Refractory Tumor
- Solid Tumor
- Dendritic Cell Vaccine
- +2 more
-
Kaohsiung, Taiwan
- +2 more
Mar 2, 2023
Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)
Recruiting
- Solid Tumor
- +11 more
-
Belfast, United Kingdom
- +16 more
Mar 2, 2023
Solid Tumor Trial in Beijing (Hemay181)
Not yet recruiting
- Solid Tumor
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Feb 27, 2023
Solid Tumor Trial in Kunming (RD14-01)
Recruiting
- Solid Tumor
- RD14-01
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Feb 18, 2023
Solid Tumor Trial (HER2-E-CART cells)
Not yet recruiting
- Solid Tumor
- HER2-E-CART cells
- (no location specified)
Feb 16, 2023
Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)
Enrolling by invitation
- Cancer
- Solid Tumor
- Personalized Synthetic Long Peptide Vaccine
-
San Francisco, CaliforniaQuest Clinical Research
Feb 20, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
Solid Tumor Trial in Chuo Ku (SAIL66, Tocilizumab)
Not yet recruiting
- Solid Tumor
-
Chuo Ku, Tokyo, JapanNational Cancer Center Hospital
Feb 9, 2023
Exploratory Drug Interaction Study Between SMIs and DOACs
Recruiting
- Solid Tumor
- Cancer, Lung
-
Nijmegen, Gelderland, Netherlands
- +1 more
Feb 7, 2023
Solid Tumor Trial in China (GT201)
Recruiting
- Solid Tumor
- GT201
-
Zhengzhou, Henan, China
- +4 more
Feb 6, 2023
Solid Tumor Trial in Shanghai (GT201)
Recruiting
- Solid Tumor
- GT201
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiaotong University School
Feb 1, 2023
Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)
Recruiting
- Solid Tumor
- Haematological Malignancy
- Alectinib
- +4 more
-
Belfast, United Kingdom
- +24 more
Jan 31, 2023
Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)
Not yet recruiting
- Hematologic Malignancy
- +2 more
- Ivaltinostat
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 6, 2023